Carcinoma, Renal Cell

Showing NaN - NaN of 25

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Carcinoma, Renal Cell Trial in United States (Belzutifan)

Recruiting
  • Carcinoma, Renal Cell
  • Boston, Massachusetts
  • +3 more
Jan 27, 2023

Carcinoma, Renal Cell Trial in Worldwide (DFF332, RAD001, PDR001)

Recruiting
  • Carcinoma, Renal Cell
  • Duarte, California
  • +10 more
Jun 13, 2022

Carcinoma, Renal Cell Trial in Worldwide (tivozanib HCl, Sorafenib)

Completed
  • Carcinoma, Renal Cell
  • Phoenix, Arizona
  • +190 more
Jan 18, 2022

Carcinoma, Renal Cell Trial in Worldwide (Regorafenib (Stivarga, BAY73-4506))

Completed
  • Carcinoma, Renal Cell
  • Regorafenib (Stivarga, BAY73-4506)
  • Los Angeles, California
  • +17 more
Jan 27, 2021

Carcinoma, Renal Cell Trial in Houston (TroVax, IL-2)

Completed
  • Carcinoma, Renal Cell
  • Houston, Texas
    The Methodist Hospital
Oct 9, 2020

Data and Safety in Patients Receiving Pazopanib With Advanced or

Completed
  • Carcinoma, Renal Cell
  • Phoenix, Arizona
  • +143 more
Jul 14, 2020

NSCLC, Carcinoma, Renal Cell, Breast Tumors Trial in United States (SGN-2FF, pembrolizumab)

Terminated
  • Carcinoma, Non-Small-Cell Lung
  • +7 more
  • Birmingham, Alabama
  • +10 more
Jul 17, 2019

Carcinoma, Renal Cell Trial in Worldwide (Pazopanib)

Completed
  • Carcinoma, Renal Cell
  • Duarte, California
  • +18 more
Mar 4, 2019

Carcinoma, Renal Cell Trial in Houston (Sunitinib, Temsirolimus, Sorafenib)

Terminated
  • Carcinoma, Renal Cell
  • Houston, Texas
    UTHealth Memorial Hermann Cancer Center
Sep 12, 2018

Carcinoma, Renal Cell Trial in Worldwide (axitinib)

Completed
  • Carcinoma, Renal Cell
  • Antioch, California
  • +64 more
Apr 18, 2017

Carcinoma, Renal Cell Trial in Houston (Bevacizumab, Interleukin-2)

Terminated
  • Carcinoma, Renal Cell
  • Houston, Texas
    Baylor College of Medicine - Methodist Hospital
Mar 15, 2016

Carcinoma, Renal Cell Trial in Houston (Pegylated Alfa Interferon, sunitinib, erlotinib)

Terminated
  • Carcinoma, Renal Cell
  • Pegylated Alfa Interferon
  • +2 more
  • Houston, Texas
    Baylor College of Medicine - Methodist Hospital
Mar 15, 2016

Carcinoma, Renal Cell Trial in Houston (RAD001, Sorafenib)

Completed
  • Carcinoma, Renal Cell
  • Houston, Texas
    The Methodist Hospital Research Institute
Mar 15, 2016

Carcinoma, Renal Cell Trial in Houston (Sorafenib)

Completed
  • Carcinoma, Renal Cell
  • Houston, Texas
    Methodist Hospital - Baylor College of Medicine
Mar 15, 2016

Carcinoma, Renal Cell Trial in Houston (RAD001)

Completed
  • Carcinoma, Renal Cell
  • Houston, Texas
    Baylor College of Medicine - Methodist Hospital
Mar 15, 2016

Carcinoma, Renal Cell Trial in Houston (TroVax® (Immunological Vaccine Therapy), Interferon-alpha)

Completed
  • Carcinoma, Renal Cell
  • Houston, Texas
    Baylor College of Medicine - Methodist Hospital
Mar 15, 2016

Carcinoma, Renal Cell Trial in United Kingdom, United States (Sorafenib (Nexavar, BAY43-9006), Placebo)

Completed
  • Carcinoma, Renal Cell
  • Sorafenib (Nexavar, BAY43-9006)
  • Placebo
  • Chicago, Illinois
  • +6 more
Dec 18, 2014

Carcinoma, Renal Cell, Lymphoma, Non-Hodgkin Trial in United States (SGN-75)

Completed
  • Carcinoma, Renal Cell
  • Lymphoma, Non-Hodgkin
  • Birmingham, Alabama
  • +8 more
Dec 17, 2014

Carcinoma, Renal Cell Trial in Canada, United States (Sorafenib (Nexavar, BAY43-9006))

Completed
  • Carcinoma, Renal Cell
  • Sorafenib (Nexavar, BAY43-9006)
  • Bessemer, Alabama
  • +319 more
Aug 5, 2014

Carcinoma, Renal Cell, Kidney Tumors Trial in Worldwide (Interferon Alfa, CCI-779, Interferon Alfa and CCI-779)

Completed
  • Carcinoma, Renal Cell
  • Kidney Neoplasms
  • Interferon Alfa
  • +2 more
  • Little Rock, Arkansas
  • +153 more
Sep 24, 2012

Carcinoma, Renal Cell Trial in Worldwide (Interferon-alfa, SU011248)

Completed
  • Carcinoma, Renal Cell
  • Jonesboro, Arkansas
  • +123 more
Jan 19, 2010

Carcinoma, Renal Cell Trial in United States (Recombinant Human Lactoferrin)

Completed
  • Carcinoma, Renal Cell
  • Recombinant Human Lactoferrin
  • Los Angeles, California
  • +5 more
Apr 8, 2008

Carcinoma, Renal Cell Trial in Netherlands, United States (ABT-510/Thrombospondin-1 mimetic)

Completed
  • Carcinoma, Renal Cell
  • ABT-510/Thrombospondin-1 mimetic
  • Scottsdale, Arizona
  • +17 more
Aug 13, 2007

Carcinoma, Renal Cell, Urogenital Tumors, Urologic Tumors Trial in Houston (motexafin gadolinium)

Completed
  • Carcinoma, Renal Cell
  • +3 more
  • motexafin gadolinium
  • Houston, Texas
    Methodist Hospital
Mar 2, 2007